DATE : 2023-05-14
ATTENDEES : PERSON125, PERSON126


SUMMARY
- The European Union supports access to affordable pharmaceutical products in poor developing countries and LDCs.
- EU member states are free to use the exceptions provided under the TRIPS Agreement in their domestic patent laws.
- The EU supports initiatives encouraging the transfer of technology, research, capacity strengthening, regional supply systems


Minuted by: Team Synapse